Humanized antibodies that recognize beta amyloid peptide

Details for Australian Patent Application No. 2003214152 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 60/363751 12.03.02 US

6 November 2003 Application Open to Public Inspection

Published as AU-B-2003214152

20 December 2007 Assignment before Grant

Wyeth; Neuralab Limited The application has been assigned to Wyeth; Elan Pharma International Limited

27 August 2009 Application Accepted

Published as AU-B-2003214152

24 December 2009 Standard Patent Sealed

8 April 2010 Alteration of Name

The name of the patentee has been altered to Elan Pharma International Limited; Wyeth LLC

26 April 2012 Assignment Registered

Wyeth LLC; Elan Pharma International Limited The patent has been assigned to Janssen Alzheimer Immunotherapy; Wyeth LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.